A Two-year Study to Evaluate the Efficacy and Safety of Deferasirox Film-coated Tablet Versus Phlebotomy in Patients With Hereditary Hemochromatosis
Study description
A phase II, multicenter, open-label, randomized two-year studyto evaluate the efficacyand safetyof deferasirox film-coated tablet versus phlebotomyin patients with Hereditary Hemochromatosis
Pathology
Hereditary Hemochromatosis
Study type
Clinical trial
Status
Active
Study start date
2018
Funder Type
Industry funded study
Investigator
Dr.ssa med. Benedetta TERZIROLI BERETTA-PICCOLI
Recruitment
Recruiting
For information, please contact the Foundation